Organogenesis Holdings (ORGO) Gross Margin (2017 - 2025)
Historic Gross Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 64.73%.
- Organogenesis Holdings' Gross Margin fell 120000.0% to 64.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.27%, marking a year-over-year decrease of 90200.0%. This contributed to the annual value of 75.99% for FY2024, which is 5700.0% up from last year.
- Per Organogenesis Holdings' latest filing, its Gross Margin stood at 64.73% for Q3 2025, which was down 120000.0% from 51.55% recorded in Q2 2025.
- Over the past 5 years, Organogenesis Holdings' Gross Margin peaked at 78.05% during Q2 2022, and registered a low of 51.55% during Q2 2025.
- Its 5-year average for Gross Margin is 73.82%, with a median of 75.48% in 2024.
- In the last 5 years, Organogenesis Holdings' Gross Margin skyrocketed by 55800bps in 2021 and then plummeted by -260300bps in 2025.
- Over the past 5 years, Organogenesis Holdings' Gross Margin (Quarter) stood at 74.51% in 2021, then increased by 3bps to 76.53% in 2022, then fell by -6bps to 72.13% in 2023, then grew by 5bps to 75.48% in 2024, then fell by -14bps to 64.73% in 2025.
- Its Gross Margin stands at 64.73% for Q3 2025, versus 51.55% for Q2 2025 and 72.64% for Q1 2025.